The c.1442C>G variant in MYOC is a missense variant predicted to cause substitution of Proline by Arginine at amino acid 481 (p.Pro481Arg). This variant was not found in any genetic ancestry group of gnomAD (v4.1.0), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a genetic ancestry group of at least 10,000 alleles. The REVEL score = 0.853, which was within the 0.773-0.931 range for PP3_Moderate, predicting a damaging effect on MYOC function. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. Only 1 proband with primary open angle glaucoma had been reported (PMID: 12789574), not meeting the ≥ 2 probands threshold required to meet PS4_Supporting. Another missense variant (c.1442C>T, p.Pro481Leu, Grantham score = 98, ClinVar ID: 1686789) at the same codon has been classified as likely pathogenic for juvenile open angle glaucoma by the ClinGen Glaucoma VCEP. The c.1442C>G, p.Pro481Arg variant has a higher Grantham score (= 103) than the previously classified amino acid change, was not predicted to affect splicing as assessed with SpliceAI (≤ 0.2), and met PP3, meeting the conditions for PM5_Supporting to apply. In summary, this variant met the criteria to receive a score of 4 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5, adapted from PMID: 32720330) for primary open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v2.0.0, 5 Dec 2024): PP3_Moderate, PM2_Supporting, PM5_Supporting.